COLISTIMETHATE SODIUM CAS No.8068-37-9
GMP ISO FDA 1 Inquiries
8068-37-9
Pharmaceutical grade
99%
Shanghai
JINLAN PHARM
25Kg/drum
2022-12-31
additives,pharmaceutical chemicals,organic intermediate,chemical intermediates,Pharmaceutical Intermediates,catalyst
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceIn colistin, five of the terminal amino groups of the α-aminobutyric acid fragment may be readily alkylated. In colistimethatesodium, pentasodium colistinmethanesulfonate,sodium colistimethanesulfonate (Coly-Mycin M), the methanesulfonate radical is the attached alkyl group, and asodium salt may be made through each sulfonate. This providesa highly water-soluble compound that is very suitablefor injection. In the injectable form, it is given intramuscularlyand is surprisingly free from toxic reactions comparedwith polymyxin B. Colistimethate sodium does not readilyinduce the development of resistant strains of microorganisms,and there is no evidence of cross-resistance with thecommon broad-spectrum antibiotics. It is used for the sameconditions mentioned for colistin.CertificatesBasic Info
-
Product Name:
COLISTIMETHATE SODIUM
Other Name:COLISTIMETHATE SODIUM;ColistinSulphomethate;Colimicina;Colimyscine;COLISTIMETHATE SODIUM USP/EP/BP
CAS No.:8068-37-9
Molecular Formula:C58H105N16Na5O28S5
Molecular Weight:0
Categories:
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
additives,pharmaceutical chemicals,organic intermediate,chemical intermediates,Pharmaceutical Intermediates,catalyst
-
Location:
hangzhou,zhejiang
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
30
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
-
Year of Establishment:
2020
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
Turkey
COLISTIMETHATE SODIUM
120.00 KG Dec 30, 2024 Post an enquiry for this product